PubMed:27149138 / 7423-7591 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/27149138","sourcedb":"PubMed","sourceid":"27149138","text":"Patients with UC treated with infliximab plus AZA were more likely to achieve corticosteroid-free remission at 16 weeks than those receiving either monotherapy (10,12).","tracks":[{"project":"sentences","denotations":[{"id":"TextSentencer_T72","span":{"begin":0,"end":168},"obj":"Sentence"},{"id":"T72","span":{"begin":0,"end":168},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T72","pred":"source","obj":"sentences"},{"subj":"T72","pred":"source","obj":"sentences"}]},{"project":"Inflammaging","denotations":[{"id":"T72","span":{"begin":0,"end":168},"obj":"Sentence"},{"id":"T72","span":{"begin":0,"end":168},"obj":"Sentence"}],"attributes":[{"subj":"T72","pred":"source","obj":"Inflammaging"},{"subj":"T72","pred":"source","obj":"Inflammaging"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"sentences","color":"#a493ec","default":true},{"id":"Inflammaging","color":"#9bec93"}]}]}}